Allergan biocell textured implants lawsuit
After being recalled by the FDA, Allergan is forced to pull all of its Biocell textured breast implants from the market. As studies continue to show a clear correlation between these particular breast implants and a rare form of non-Hodgkin's lymphoma, countless lawsuits are being filed on behalf of those negatively impacted by the Allergan implants. If you or someone you love has been diagnosed with cancer or had other complications as a result of Allergan's Biocell textured implant, you may be eligible to receive substantial compensation without ever going to court. Fill out our free case review today to find out if you could be eligible.
Biocell textured surface implants, manufactured by Allergan, are recalled due to cancer risk
Late last year, the U.S. Food and Drug Agency (FDA) called for the removal of certain breast implants that had been linked to cancer. A rare form of non-Hodgkin's lymphoma, known as breast implant-associated anaplastic large cell lymphoma (ALCL), was found to be connected to patients who had implanted the Allergan BIOCELL textured breast implants. The disease is not breast cancer but a type of lymphoma that grows in the scar tissue surrounding the breasts. While this typically means that the ALCL is easily removed from the body, it has been found to spread throughout the body.
Before the recall, the agency noted that the cancer cases appeared to be more common among women using breast implants with textured surfaces, as opposed to smooth breast implants, but a definitive connection was not made. The FDA called for this removal after new information showed that the Biocell breast implants with a textured surface manufactured by Allergan accounted for a disproportionate number of these rare lymphoma cancer cases. The FDA first reported a link between implants and ALCL in 2011, and information was added to the products’ labeling. But the added warnings were deeply embedded in a dense list of complications.
The textured Biocell surface was designed to prevent slippage and to minimize scar tissue. These implants account for only about 5 percent of the U.S. market. The vast majority of breast implants used in the U.S. have a smooth surface. This recall does not affect Allergan’s smooth implants or a different Allergan textured implant sold under the Microcell Brand. Because the cancer is so rare, the agency is not yet recommending that women with these types of implants remove them. But they say women should check with their doctor if they have symptoms, which include pain and swelling. The FDA’s move follows similar recalls in France, Australia and Canada.
A look at the numbers
Roughly 400,000 U.S. women get breast implants each year and the FDA estimates that hundreds of thousands of U.S. women have the Biocell Implants. The FDA said the latest figures show more than 80 percent of the 570 confirmed cases of ALCL worldwide have been linked to Allergan implants. Regulators estimate that the risk of the disease is six times higher with Allergan implants than other textured implants sold in the U.S.
However, there is no firm agreement on the exact frequency of this cancer. Published estimates range from 1 in 3,000 patients to 1 in 30,000 patients. Researchers from Australia’s Therapeutic Goods Administration published a study in May indicating that side effects of textured breast implants may be linked to a 14 times higher risk of ALCL in some cases.
We're here to help
Although rare, complications from ALCL can be devastating. Main Street Law Firm is here to help individuals who have suffered adverse side effects, including ALCL, from Allergan's textured breast implants. If you or someone you know has developed ALCL after implanting the Allergan Biocell textured implant, you may be entitled to significant compensation without ever going to court. We believe Allergan ought to be held accountable for failing to adequately warn consumers of these risks. Fill out our free case review and we’ll help you determine if you have a claim, navigate the process, and maximize your potential compensation. If you don't receive a recovery through a lawsuit or settlement, you don’t owe us anything.